Johns Hopkins Medicine has established the Early‑Onset Colorectal Cancer Center to provide specialized care and research for younger adults in the U.S. [1].
The center addresses a critical public health shift as colorectal cancer becomes more prevalent among younger populations. This trend necessitates a multidisciplinary approach to treatment that differs from the care provided to elderly patients.
Located at Johns Hopkins Hospital in Baltimore, Maryland, the center is led by Dr. John Migaly, the chief of colorectal surgery [1]. The facility integrates collaborative care, dedicated research programs, and clinical trials specifically designed for those diagnosed with colorectal cancer at an early age [1].
Medical data highlights the urgency of these specialized services. Colorectal cancer is now the leading cause of cancer‑related death among people under 50 in the United States [2]. The biological nature of these cases also differs from late-onset versions of the disease.
Research indicates that early‑onset tumors show approximately a 12-year acceleration in DNA methylation age [3]. This biological acceleration suggests that the disease may progress or develop differently in younger patients, further justifying the need for a dedicated center of excellence.
Dr. Migaly and his team focus on a comprehensive model of care. This approach combines surgical intervention with ongoing research to better understand why the incidence of the disease is rising among younger adults [1]. The center aims to bridge the gap between general oncology and the specific needs of the under-50 population [1].
“Colorectal cancer is now the leading cause of cancer‑related death among people under 50 in the United States”
The establishment of a dedicated center for early-onset colorectal cancer reflects a growing medical consensus that younger patients are not simply 'older patients who got sick early.' The significant gap in DNA methylation age suggests a distinct biological profile for these tumors, meaning standard treatment protocols may need adjustment to improve survival rates for the under-50 demographic.
